Aloe Gator SPF 40+ Sunscreen Recalled for Out-of-Specification Active Ingredients
ARG Laboratories is recalling 4,013 units of Aloe Gator SPF 40+ sunscreen (Lot 04023C1) distributed nationwide because the active ingredient does not meet specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for a quality control issue (out-of-specification active ingredients) with no reported illnesses, injuries, or hospitalizations. Per the severity rubric, Class II recalls without reported harm and involving precautionary quality issues are classified as Moderate.
Plain-English summary
ARG Laboratories, Inc. is recalling Aloe Gator Original Formula SPF 40+ Broad Spectrum Protective Gel sunscreen because the active ingredients do not meet specifications.
The recall affects approximately 4,013 units distributed nationwide. The affected product is supplied in 1 OZ (28 g) sizes with Lot 04023C1 and expiration date 01/31/2025.
The product's active ingredients are Octocrylene 8%, Octyl Methoxycinnamate 6%, Benzophone 3 6%, and Octyl Salicylate 5%. Out-of-specification active ingredients may affect the product's ability to provide the stated sun protection.
This is a Class II recall by the U.S. Food and Drug Administration.
The recalled product
- Product
- ALOE GATOR, (Octocrylene 8%, Octyl Methoxycinnamate 6%, Benzophone 3 6%, Octyl Salicylate 5%), Original Formula, SPF 40+, Broad Spectrum Protective Gel, Sport Performance, NET WT 1 OZ (28 g), Manufactured for AGS Brands.
- Manufacturer
- ARG Laboratories, Inc.
- Category
- Drug — Sunscreen / OTC Topical
- Hazard
- out-of-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 04023C1
- Exp 01/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27